» Articles » PMID: 37153040

Primary Pulmonary Intravascular Large B‑cell Lymphoma Misdiagnosed As Pneumonia: Four Case Reports and a Literature Review

Overview
Journal Oncol Lett
Specialty Oncology
Date 2023 May 8
PMID 37153040
Authors
Affiliations
Soon will be listed here.
Abstract

Primary pulmonary intravascular large B-cell lymphoma (IVLBCL) is a rare, malignant extranodal lymphoma. It is difficult to diagnose clinically as it requires a combination of clinical and computed tomography (CT) evaluations, as well as laboratory and pathological examinations. In the present study, 4 cases of primary pulmonary IVLBCL were reviewed. The patients' ages ranged from 60 to 69 years old. Of the 4 patients, 3 developed progressive dyspnea on exertion and intermittent fever. Other symptoms included coughing, chest tightness and weight loss. Laboratory data indicated that all patients had anemia, thrombocytopenia, hypoxemia, a markedly high serum lactate dehydrogenase level, elevated erythrocyte sedimentation rate and increased C-reactive protein. CT demonstrated increased attenuation in bilateral lung parenchyma, especially in the upper lobes, with multiple ground-glass opacities associated with small nodules in these patients. Initially, all 4 patients were misdiagnosed with pneumonia. However, none of them responded to anti-inflammatory treatments. The pathologies of all patients were confirmed using lung biopsy. Only 1 patient received regular combination chemotherapy. Based on the observations of the present study, a standard regimen for lymphoma treatment may result in a notable clinical response.

Citing Articles

CT-Imaging Manifestations and Diagnostic Insights in Pulmonary Intravascular Large B-Cell Lymphoma: A Case Series and Literature Review.

Gou X, Zhang Y, Li Y, Hu L, Cheng J, Hong N Cancer Rep (Hoboken). 2025; 8(3):e70159.

PMID: 40019334 PMC: 11869564. DOI: 10.1002/cnr2.70159.


Primary pulmonary intravascular large B‑cell lymphoma: Indications from cytomorphology findings through CT‑guided puncture: A case report.

Jiang W, Li M, Zhang C, Xing X Oncol Lett. 2024; 29(1):46.

PMID: 39564372 PMC: 11574580. DOI: 10.3892/ol.2024.14792.

References
1.
Matea F, Alowami S, Bonert M, Sur M, Shargall Y, Naqvi A . Pulmonary Intravascular B-Cell Lymphoma with Angiotropism/Angioinvasion Mimicking Interstitial Lung Disease: A Clinical Dilemma and Potential Diagnostic Challenge. Case Rep Hematol. 2018; 2018:3821392. PMC: 6196920. DOI: 10.1155/2018/3821392. View

2.
Wu F, Wang Z, Xing X, Yu M, Shi B . The Value of 18F-FDG PET/CT in Diagnostic Procedure of Intravascular Large B-Cell Lymphoma Presenting Fever of Unknown Origin and Pulmonary Hypertension as an Initial Manifestation. Clin Nucl Med. 2016; 41(6):506-7. DOI: 10.1097/RLU.0000000000001188. View

3.
He X, Chen Z, Fu T, Jin X, Yu T, Liang Y . Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: evidence from a systematic meta-analysis. BMC Cancer. 2014; 14:153. PMC: 3995999. DOI: 10.1186/1471-2407-14-153. View

4.
Spencer J, Dusing R, Yap W, Hill J, Walter C . Intravascular large B-cell lymphoma presenting with diffusely increased pulmonary fluorodeoxyglucose uptake without corresponding CT abnormality. Radiol Case Rep. 2018; 14(2):260-264. PMC: 6260434. DOI: 10.1016/j.radcr.2018.10.035. View

5.
Scott D, Mottok A, Ennishi D, Wright G, Farinha P, Ben-Neriah S . Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies. J Clin Oncol. 2015; 33(26):2848-56. PMC: 4554747. DOI: 10.1200/JCO.2014.60.2383. View